Ensysce Biosciences, Inc.
Clinical-stage pharma firm developing abuse-deterrent drugs for severe pain.
ENSC | US
Overview
Corporate Details
- ISIN(s):
- US2936021086 (+2 more)
- LEI:
- Country:
- United States of America
- Address:
- 7946 IVANHOE AVENUE, 92037 LA JOLLA
- Website:
- https://ensysce.com/
Description
Ensysce Biosciences, Inc. is a clinical-stage pharmaceutical company developing solutions for severe pain relief, with a focus on stemming the prescription drug abuse epidemic. The company utilizes proprietary prodrug technology platforms to create safer prescription drugs. Its lead product candidate, PF614, is a next-generation opioid designed with Trypsin-Activated Abuse Protection (TAAP™) to deter abuse via injection or inhalation. PF614 has received Fast Track and Breakthrough Therapy designations from the U.S. Food and Drug Administration (FDA). Ensysce is also developing its Multi-Pill Abuse Resistance (MPAR®) technology, an overdose protection platform designed to prevent respiratory depression when multiple doses are consumed. The company's goal is to provide effective pain management while reducing the potential for misuse, abuse, and overdose.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Ensysce Biosciences, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Ensysce Biosciences, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Ensysce Biosciences, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
